ResearcherCity of HopeActive in the last 2 years
Todd A. DeWees
Matched on ORCID iD 0000-0003-3897-3011; OpenAlex author ID A5039358235. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2023: 1 paper · 2024: 1 paper
Papers 2
- Determining the Minimal Clinically Important Difference of the Functional Assessment of Cancer Therapy Hepatobiliary Questionnaire to Evaluate the Change in th… Last author DOI 10.1016/j.ijrobp.2023.08.009↗
- MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A TITE-CRM Phase I Trial. Co-author DOI 10.1016/j.ijrobp.2022.07.015↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christopher Leigh Hallemeier · 1 shared paper, 2024 · strength 0.20
- Isabella Zaniletti · 1 shared paper, 2024 · strength 0.20
- Kenneth Wing Merrell · 1 shared paper, 2024 · strength 0.20
- Michael G. Haddock · 1 shared paper, 2024 · strength 0.20
- William G. Hawkins · 1 shared paper, 2023 · strength 0.14
- Michael Charles Roach · 1 shared paper, 2023 · strength 0.14
- Benjamin R. Tan · 1 shared paper, 2023 · strength 0.14
- Katrina Sophia Pedersen · 1 shared paper, 2023 · strength 0.14
- Hyun Jee Kim · 1 shared paper, 2023 · strength 0.14
- Kian‐Huat Lim · 1 shared paper, 2023 · strength 0.14
- Lauren E. Henke · 1 shared paper, 2023 · strength 0.14
- Parag Jitendra Parikh · 1 shared paper, 2023 · strength 0.14
- Shahed Nicolas Badiyan · 1 shared paper, 2023 · strength 0.14
- Ryan C Fields · 1 shared paper, 2023 · strength 0.14
- Andrea Wang‐Gillam · 1 shared paper, 2023 · strength 0.14
- Chet W. Hammill · 1 shared paper, 2023 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.